hummm,,possibly you are all correct,,,,but book value is usually not that juicy for any investor,,,,I am of the opposite opinion as far as to what company should remain private and what should become public......as we see, public companies can be very tight lipped,,,, I own enuff of these public companies as you all do to know so,,,,,&,,,,,as far as having a choice as to which company is public,,then I would choose hands down Zenith Capital Corp,,let the spin off companies ,,or the satilite companies as has been referred to be the private sales down the road. It is a dis-service to all existing shareholders to offer or maintain 0 liquidity in their shares imo. It has been 5 1/2 years since our original invested dollars have been sequestered by DM,,its well past time the open market is allowed to value this science. Certainly if BoM data proves the science of epigenetics has come of age. Perhaps a successful BoM is such an event to trigger a listing,,,,,perhaps,,,,,,,,,,jmo